EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MicroRNA-21 in gynecological cancers: From molecular pathogenesis to clinical significance

Ni-Jie Jiang, Ya-Nan Yin, Jiao Lin, Wen-Yuan Li, De-Rong Long, Ling Mei

Pathology - Research and Practice · 2023-08 · 248 · 154630

DOI: 10.1016/j.prp.2023.154630 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023-08. Verfasst von Ni-Jie Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics Nursing, West China Second University Hospital Sichuan University, Chengdu, 610041, China; Key Laboratory of …. Hauptthemen laut MEDLINE: MicroRNAs, Endometrial Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 103 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian, cervical, and endometrial cancers are the three most common gynecological cancer types (GCs). They hold a significant position as the leading causes of mortality among women with cancer-related death. However, GCs are often diagnosed late, severely limiting the efficacy of current treatment options. Thus, there is an urgent, unmet need for innovative experimentation to enhance the clinical treatment of GC patients. MicroRNAs (miRNAs) are a large and varied class of short noncoding RNAs (22 nucleotides in length) that have been shown to play essential roles in various biological processes involved in development. Recent research has shown that miR-211 influences tumorigenesis and cancer formation, adding to our knowledge of the miR-21 dysregulation in GCs. Furthermore, current research that sheds light on the crucial functions of miR-21 may provide supporting evidence for its potential prognostic, diagnostic, and therapeutic applications in the context of GCs. This review will thus focus on the most recent findings concerning miR-21 expression, miR-21 target genes, and the processes behind GCs. In addition, the latest findings that support miR-21's potential use as a non-invasive biomarker and therapeutic agent for detecting and treating cancer will be elucidated in this review. The roles played by various lncRNA/circRNA-miRNA-mRNA axis in GCs are also comprehensively summarized and described in this study, along with any possible implications for how these regulatory networks may contribute to the pathogenesis of GCs. Also, it is crucial to recognize the complexity of the processes involved in tumour therapeutic resistance as a significant obstacle in treating GCs. Furthermore, this review provides an overview of the current state of knowledge regarding the functional significance miR-21 in therapeutic resistance within the context of GCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsEndometrial NeoplasmsHumansFemaleClinical RelevancePrognosis

Stichwörter der Autor:innen

BiomarkerGynecological cancerMiR-21

Substanzen

MicroRNAsMIRN21 microRNA, human

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics Nursing, West China Second University Hospital Sichuan University, Chengdu, 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children Sichuan Unive…
  • West China Nursing School, Sichuan University, Chengdu, 610041, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children Sichuan University, Ministry of Education, Chengdu, 610041, China; Department of Gynecology and Obstetrics, West China Second Hospital of Sichua…

Zitieren

APA

Jiang, N. J., Yin, Y. N., Lin, J., Li, W. Y., Long, D. R., & Mei, L. (2023). MicroRNA-21 in gynecological cancers: From molecular pathogenesis to clinical significance. Pathology - Research and Practice, 248, 154630. https://doi.org/10.1016/j.prp.2023.154630

Vancouver

Jiang NJ, Yin YN, Lin J, Li WY, Long DR, Mei L. MicroRNA-21 in gynecological cancers: From molecular pathogenesis to clinical significance. Pathology - Research and Practice. 2023;248:154630. doi:10.1016/j.prp.2023.154630

BibTeX
@article{Jiang2023,
  author = {Jiang, Ni-Jie and Yin, Ya-Nan and Lin, Jiao and Li, Wen-Yuan and Long, De-Rong and Mei, Ling},
  title = {MicroRNA-21 in gynecological cancers: From molecular pathogenesis to clinical significance},
  journal = {Pathology - Research and Practice},
  year = {2023},
  volume = {248},
  pages = {154630},
  doi = {10.1016/j.prp.2023.154630}
}
Kostenlos starten →